((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate(1:x)

Catalog No. :
ACVVEN532
CAS No. :
206860-46-0
Molecular Formula :
C10H17BrO5S
Molecular Weight :
329.21

IUPAC Name:((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate

((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate(1:x) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$92.00Login to see priceInquiryInquiry
25g95%$189.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate(1:x)
IUPAC Name((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate
MDL No.MFCD00167452
Molecular FormulaC10H17BrO5S
Molecular Weight329.21
SMILESO=S(C[C@@]1(C2(C)C)C([C@@H](Br)[C@@]2([H])CC1)=O)(O)=O.[H]O[H]
InChI KeyRQZLIPHNDCFLPR-OFVIFIGMSA-N
Synonym[(1S)-ENDO]-(+)-3-BROMO-10-CAMPHORSULFONIC ACID MONOHYDRATE | (1S)-(+)-3-Bromocamphor-10-sulfonic acid hydrate | CS-W021054 | ((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | AT25353 | C10H17BrO5S | DS-11281 |
CAS No.206860-46-0
PubChem CID71306285

Synthetic Route by SureRoute

1. ACVVEN532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVVEN532 route product structure diagram
    ACVVEN532206860-46-0
Inquiry

2. ACVVEN532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVVEN532 route product structure diagram
    ACVVEN532206860-46-0
Inquiry

Comments (0)